Sucraid oral solution is an enzyme replacement therapy (ERT) for genetically determined sucrase deficiency, which is part of a rare, chronic disease, congenital sucrase-isomaltase deficiency (CSID).
Ethamolin (Ethanolamine Oleate injection, 5%, 2mL ampules) is a mild sclerosing agent, used to treat patients with esophageal varices that have recently bled, to prevent rebleeding.
QOL Medical chief operating officer Derick Cooper said their company is seeking to jointly make life changing medications available to patients in Canada, along with Medunik Canada.
"Our company’s mission is to assist in expanding disease awareness to aid physicians with identifying these rare diseases and to assist, directly and with partners like Médunik Canada, in making the proper treatments available to physicians and patients," Cooper added.